The Lifelong Contract – How the Same Logic That Created the Crisis Now Runs Treatment

The same financial logic that created this epidemic is now running the treatment. Different investors, same math. We were worth more sick than healthy — and apparently we still are.

My Entry Into the System

I didn't choose methadone exactly. It was a condition of getting into Guelph's Drug Treatment Court, which was a condition of getting out of jail. I was the first person through when they launched it.

Methadone seemed excessive to me back then. We were on Oxys. I'd kicked it a few times. I wanted out of jail so I agreed. What I didn't understand was that I was signing a contract with my body. Methadone lingers. I'm a lifer. That's not a complaint. It's context.

How We Got Here

We grew up in the west end suburbs. Played hockey and football. Oxys had been marketed as a miracle pill. Then they banned the old OxyContin and brought in hydros and morphine. The supply changed. The need didn't.

Methadone was the answer. It was going to clean up the streets and save the system money. In the beginning that's enough.

The Ceiling Nobody Talks About

What doesn't get talked about is the ceiling. What do we do with the people who don't come off it? I never felt truly encouraged to taper. The clinical reasoning makes a kind of sense — you're safer here. But the question that never gets asked out loud is what does this system actually want for us long term?

What I Discovered About Profit

CATC — Canadian Addiction Treatment Centres — was sold to an American private equity firm. BayMark Health Services, backed by Webster Equity Partners, acquired them. In 2022 they added Trafalgar Addiction Treatment Centre. Industry reports had them marketing the operation again in 2025 with earnings around $75 million.

Seventy-five million dollars. In the middle of an opioid epidemic.

The incentives don't align. A private equity firm has a fiduciary responsibility to its investors. That obligation and a genuine orientation toward getting people off medication pull in opposite directions.

The most valuable patient in this model is the stable, long-term patient who keeps showing up. I am that patient. I am the lifelong contract.

Where the Money Goes

Ontario taxpayers fund this through OHIP and the Ontario Drug Benefit. Public money flows in, and after local costs, the upside travels south. Most people paying into this system have no idea.

What I Actually Want

I'm not writing this to tear down methadone or MAT programs. I've been on this medication for over a decade and it has kept me alive and functional. That's real.

But I've been watching this system since 2011. The clinics haven't fundamentally changed in the ways that matter most. Volume has increased. Accessibility has increased. But I still can't get into detox when I need it. The counseling often feels like data collection more than support.

Here is what I want: Transparency about who owns the clinics and where the profit flows. An honest accounting of long-term outcomes. Services that reflect what recovery actually requires — not just the dose, but housing help, consistent counseling, and a sense that someone is invested in where you end up.

The Dark Through-Line

There's a dark through-line in all of this. The original opioid crisis was the result of aggressive marketing and decisions made by people who profited enormously. Then the crisis hit and public money moved toward treatment. New system. Same logic. The investors repositioned.

Now instead of profiting off the pills, they profit off the people trying to survive them.

We were a revenue stream going in. We're a revenue stream coming out. The only people who never made money in any of this were us.